Description
Added on the 16/03/2021 15:26:36 - Copyright : France 24 EN
WHO director for regulation and pre-qualification Rogerio Pinto de Sa Gaspar says the risk-benefit balance for the AstraZeneca Covid-19 vaccine is "still largely positive". The EU's drug regulator, the European Medicines Agency, has said it is still deciding whether the AstraZeneca coronavirus vaccine causes blood clots, after one top official said there was a clear link. SOUNDBITE
The EU's drug regulator says it remains "firmly convinced" of the benefits of AstraZeneca's coronavirus vaccine despite several countries suspending its use over blood clot fears. SOUNDBITE
London, Apr 8 (EFE/EPA).- (Camera: EFE/EPA archive) The British Minister of Health, Matt Hancock, encouraged citizens on Thursday to continue to get vaccinated and restated that the risk of developing thrombosis is very low in the case of being immunized with the AstraZeneca vaccine.ARCHIVE FOOTAGE OF VACCINATION CENTRES IN THE UK.
The chief executive of Britain's independent medicines regulator, June Raine, announces that out of 79 cases of blood clots in people having received a first dose of the Oxford-AstraZeneca vaccine, 19 people have died, during a press conference over concerns about links between AstraZeneca's Covid-19 vaccine and blood clots. SOUNDBITE
EMA Executive Director Emer Cooke says no specific risk factors are associated with clotting disorders resulting from the AstraZeneca coronavirus vaccine. SOUNDBITE
Executive Director of the European Medicines Agency (EMA) Emer Cook says the AstraZeneca vaccine is "safe and effective" and not associated with a higher blood clot risk, after more than a dozen countries paused rollouts over health fears. IMAGES
|
Support : Technical 
- Content 
- Editors 
